Journal of Genetic Medicine

Korean Society of Medical Genetics and Genomics (대한의학유전학회)
권호 표지

Hereditary Colorectal Cancer

유전성 대장암

  • Kim, Duck-Woo (Department of Surgery, Seoul National University Bundang Hospital)
  • 김덕우 (분당서울대학교병원 외과)
  • Received : 2010.06.06
  • Accepted : 2010.06.25
  • Published : 2010.03.01
Download PDF
⟨ Previous Next ⟩

Abstract

Colorectal cancer is one of the most steeply increasing malignancies in Korea. Among 398,824 new patients recorded by the Korea Central Cancer Registry between 2003 and 2005, 47,915 cases involved colorectal cancers, accounting for 12.0 % of all malignancies. In 2002, total number of colorectal cancer cases had accounted for 11.2 % of all malignancies. Hereditary syndromes are the source of approximately 5% to 15% of overall colorectal cancer cases. Hereditary colorectal cancers are divided into two types: hereditary nonpolyposis colorectal cancer (HNPCC), and cancers associated with hereditary colorectal polyposis, including familial adenomatous polyposis (FAP), Peutz-Jeghers syndrome, juvenile polyposis, and the recently reported hMutYH (MYH)-associated polyposis (MAP). Hereditary colorectal cancers have unique clinical features distinct from sporadic cancer because these are due to germline mutations of the causative genes; (i) early age-of-onset of cancer, (ii) frequent association with synchronous or metachronous tumors, (iii) frequent association with extracolonic manifestations. The management strategy for patients with hereditary colorectal cancer is quite different from that for sporadic cancer. Furthermore, screening, genetic counseling, and surveillance for at-risk familial member are also important. A well-organized registry can plays a central role in the surveillance and management of families affected by hereditary colorectal cancers. Here, we discuss each type of hereditary colorectal cancer, focusing on the clinical and genetic characteristics, management, genetic screening, and surveillance.

대장암은 우리나라에서 가장 급격하게 발생이 증가하는 암종의 하나로 유전성 대장암은 전체 대장암의 5-15%를 차지한다. 유전성 대장암은 크게 유전성 비용종증 대장암과 유전성 용종 증후군에서 발생하는 대장암으로 나눌 수 있고, 유전성 용종 증후군에는 가족성 용종증, 포이츠-예거증후군, 유년기 용종증, MYH 연관 용종증 등이 이에 해당한다. 유전성 대장암은 원인 유전자의 배선돌연변이에 기인하므로 산발성 대장암에 비하여 암이 조기 발생하고, 동시성 및 이시성 암이 흔하며, 대장 이외의 장기에도 종양을 비롯한 질병을 일으키는 특징이 있다. 유전성 대장암은 환자뿐 아니라 가족구성원에 대한 유전자 검사, 유전 상담, 조기 진단을 위한 정기검진이 매우 중요하며, 이러한 환자 및 가족구성원의 효율적 관리를 위한 유전성종양 등록소의 역할이 중요하다. 본 논문에서는 유전성 대장암에 해당하는 질환들의 임상적/유전적 특성, 치료, 유전자 검사 및 정기검진 프로그램에 대하여 고찰하고자 한다.

Keywords

References

  1. Won YJ, Sung J, Jung KW, Kong HJ, Park S, Shin HR, et al. National Cancer Incidence in Korea, 2003-2005. Cancer Res Treat 2009;41:122-31. https://doi.org/10.4143/crt.2009.41.3.122
  2. Park JK. COLOPROCTOLOGY. 3rd ed. Seoul: Ilchokak, Inc.; 2006.
  3. Burt RW, Peterson GM. Familial colorectal cancer: diagnosis and management. In: Young GP, Roger P, Leven B, eds. Prevention and Early Detection of Colorectal Cancer. London: WB Saunders; 1996. p. 171-94.
  4. Rusin LC, Galandiuk S. Hereditary nonpolyposis colorectal cancer. In: Wolff BG, Fleshman JW, Beck DE, editors. The ASCRS Textbook of Colon and Rectal Surgery. 1st ed. New York: Springer; 2007. p. 525-42.
  5. Mitchell J, Farrington S, Dunlop M, Campbell H. Mismatch repair genes hMLHI and hMSH2 and colorectal cancer: a HuGE review. Am J Epidemiol 2002; 156:885-902. https://doi.org/10.1093/aje/kwf139
  6. Ionov Y, Punado MA, Malklosyan S, Shibata D, Perucho M. Ubiquitous somatic mutations in simple repeated sequences reveal a new mechanism for colonic carcinogenesis. Nature 1993;363:558-61. https://doi.org/10.1038/363558a0
  7. Gordon PH. Malignant neoplasms of the colon. In: Gordon PH, Nivatvongs S, editors. Principles and Practice of Surgery for the Colon, Rectum, and Anus. 3rd ed. New York: Informa Healthcare USA, Inc.; 2006. p. 489-644.
  8. Parsons R, Myeroff L, Liu B, Willson JK, Markowitz SD, Kinzler KW, et al. Microsatellite instability and mutations of the transforming growth factor ${\beta}$ type II receptor gene in colorectal cancer. Cancer Res 1995; 55:5548-50.
  9. Calin G, Gofa R, Tibiletti M, Herlea V, Becheanu G, Cavazzini L, et al. Genetic progression in microsatellite instability high (MSI-H) colon cancers correlates with clinico-pathological parameters: A study of the TGF${\beta}$ RII, BAX, hMSH3, hMSH6, IGFIIR, and BLM genes. Int J Cancer 2000;89:230-5. https://doi.org/10.1002/1097-0215(20000520)89:3<230::AID-IJC4>3.0.CO;2-J
  10. Chung D, Rustgi A. The hereditary nonpolyposis colorectal cancer syndrome: genetics and clinical implications. Ann Intern Med 2003;138:560-70. https://doi.org/10.7326/0003-4819-138-7-200304010-00012
  11. Muller A, Fishel R. Mismatch repair and the hereditary non-polyposis colorectal cancer syndrome (HNPCC). Cancer Invest 2002;20:102-9. https://doi.org/10.1081/CNV-120000371
  12. Jass JR. Pathology of hereditary nonpolyposis colorectal cancer. Ann NY Acad Sci 2000;910:62-73.
  13. Winawer SJ, Zauber AG, Ho MN, O'Brien MJ, Gottlieb LS, Sternberg SS, et al. Prevention of colorectal cancer by colonoscopic polypectomy: The National Polyp Study Workgroup. N Engl J Med 1993;329:1977-81. https://doi.org/10.1056/NEJM199312303292701
  14. Olschwang S, Slezak P, Roze M, Jaramillo E, Nakano H, Koizumi K, et al. Somatically acquired genetic alterations in flat colorectal neoplasias. Int J Cancer 1998;77: 366-9. https://doi.org/10.1002/(SICI)1097-0215(19980729)77:3<366::AID-IJC10>3.0.CO;2-6
  15. Makinen MJ, George SMC, Jemvall P, Mäkelä J, Vihko P, Karttunen TJ. Colorectal carcinoma associated with serrated adenoma-prevalence, histological features, and prognosis. J Pathol 2001;193:286-94. https://doi.org/10.1002/1096-9896(2000)9999:9999<::AID-PATH800>3.0.CO;2-2
  16. Ribic CM, Sargent DJ, Moore MJ, Thibodeau SN, French AJ, Goldberg RM, et al. Tumor microsatelliteinstability status as a predictor of benefit from fluorouracil-based adjuvant chemotherapy for colon cancer. N Engl J Med 2003;349:247-57. https://doi.org/10.1056/NEJMoa022289
  17. Elsaleh H, Joseph D, Grieu F, Zeps N, Spry N, Iacopetta B. Association of tumour site and sex with survival benefit from adjuvant chemotherapy in colorectal cancer. Lancet 2000;355:1745-50. https://doi.org/10.1016/S0140-6736(00)02261-3
  18. Aarnio M, Mecklin JP, Aaltonen LA, Nystrom-Lahti M, Järvinen HJ. Lifetime risk of different cancers in hereditary nonpolyposis colorectal cancer. Int J Cancer 1995;64:430-3. https://doi.org/10.1002/ijc.2910640613
  19. Park JG, Kim DW, Hong CW, Nam BH, Shin YK, Hong SH, et al. Germline mutations of mismatch repair genes in hereditary nonpolyposis colorectal cancer patients with small bowel cancer - InSiGHT Collaborative Study. Clin Cancer Res 2006;12:3389-93. https://doi.org/10.1158/1078-0432.CCR-05-2452
  20. Park YJ, Shin KH, Park JG. Risk of gastric cancer in hereditary nonpolyposis colorectal cancer in Korea. Clin Cancer Res 2000;6:2994-8.
  21. Wagner A, Hendricks Y, Meijers-Heyboer EJ, de Leeuw WJ, Morreau H, Hofstra R, et al. Atypical HNPCC owing to MSH6 germline mutations; analysis of a large Dutch pedigree. J Med Genet 2001;58:318-22.
  22. Vasen HFA, Mecklin J-P, Khan PM, Lynch HT. The International Collaborative Group on Hereditary Nonpolyposis Colorectal Cancer (ICG-HNPCC). Dis Colon Rectum 1991;34:424-5. https://doi.org/10.1007/BF02053699
  23. Vasen HFA, Watson P, Mecklin JP, Lynch HT. New clinical criteria for hereditary nonpolyposis colorectal cancer (HNPCC, Lynch syndrome) proposed by the International Collaborative Group on HNPCC. Gastroenterology 1999;116:1453-6. https://doi.org/10.1016/S0016-5085(99)70510-X
  24. Schwartz RA, Torre DP. The Muir-Torre syndrome: 25 year retrospect. J Am Acad Dermatol 1995;33:90-104. https://doi.org/10.1016/0190-9622(95)90017-9
  25. Park JG, Vasen HF, Park KJ, Peltomaki P, Ponz de Leon M, Rodriguez-Bigas MA, et al. Suspected hereditary nonpolyposis colorectal cancer: International Collaborative Group on Hereditary Non-Polyposis Colorectal Cancer (ICG-HNPCC) criteria and results of genetic diagnosis. Dis Colon Rectum 1999;42:710-5. https://doi.org/10.1007/BF02236922
  26. Park JG, Vasen HFA, Park YJ, Park KJ, Peltomaki P, de Leon MP, et al. Suspected HNPCC and Amsterdam criteria II: evaluation of mutation detection rate, an international collaborative study. Int J Colorectal Dis 2002:17:109-14. https://doi.org/10.1007/s003840100348
  27. Peltomaki P, Lothe RA, Aaltonen LA, Pylkkänen L, Nystrom-Lahti M, Seruca R, et al. Microsatellite instability is associated with tumors that characterize the hereditary non-polyposis colorectal carcinoma syndrome. Cancer Res 1993;53:5853-5.
  28. Boland CR, Thibodeau SN, Hamilton SR, Sidransky D, Eshleman JR, Burt RW, et al. A National Cancer Institute Workshop on Microsatellite Instability for cancer detection and familial predisposition: development of international criteria for the determination of microsatellite instability in colorectal cancer. Cancer Res 1998;58:5248-57.
  29. Shin KH, Shin JH, Kim JH, Park JG. Mutational analysis of promoters of mismatch repair genes hMSH2 and hMLH1 in hereditary nonpolyposis colorectal cancer and early onset colorectal cancer patients: identification of three novel germ-line mutations in promoter of the hMSH2 gene. Cancer Res 2002;62:38-42.
  30. Shin YK, Heo SC, Shin JH, Hong SH, Ku JL, Yoo BC, et al. Germline mutationss in MLH1, MSH2 and MSH6 in Korean hereditary non-polyposis colorectal cancer families. Human Mut 2004;24:351.
  31. Shin KH, Ku JL, Park JG. Germline mutations in a polycytosine repeat of the hMSH6 gene in Korean hereditary nonpolyposis colorectal cancer. J Hum Genet 1999;44:18-21. https://doi.org/10.1007/s100380050099
  32. Park JG, Han HJ, Won YJ, et al. Familial adenomatous polyposis and hereditary nonpolyposis colorectal cancer in Korea. In: Baba S, editor. New Strategies for Treatment of Hereditary Colorectal Cancer. Tokyo: Churchill Livingstone; 1996.
  33. Bulow S. Results of national registration of familial adenomatous polyposis. Gut 2003;52:742-6. https://doi.org/10.1136/gut.52.5.742
  34. Bodmer WF, Bailey CJ, Bodmer J, Bernstein I, Nielsen FC. Localization of the gene for familial adenomatous polyposis on chromosome 5. Nature 1987;328:614-6. https://doi.org/10.1038/328614a0
  35. Sieber OM, Lipton L, Crabtree M, Heinimann K, Fidalgo P, Phillips RK, et al. Multiple colorectal adenomas, classic adenomatous polyposis, and germ-line mutations in MYH. N Engl J Med 2003;348:791-9. https://doi.org/10.1056/NEJMoa025283
  36. Bussey HJ. Familial Polyposis Coli. Family Studies, Histopathology, Differential Diagnosis and Results of Treatment. Baltimore: Johns Hopkins University Press; 1975.
  37. Belchez LA, Berk T, Bapat BV. Changing cause of mortality in patients with familial adenomatous polyposis. Dis Colon Rectum 1996;39:387-7. https://doi.org/10.1007/BF02054051
  38. Heiskanen I, Kellokumpu I, Jarvinen H. Management of duodenal adenomas in 98 patients with familial adenomatous polyposis. Endoscopy 1999;31:412-6. https://doi.org/10.1055/s-1999-41
  39. Groves CJ, Saunders BP, Spigelman AD, Phillips RKS. Duodenal cancer in patients with familial adenomatous polyposis (FAP): results of a 10 year prospective study. Gut 2002;50:636-41. https://doi.org/10.1136/gut.50.5.636
  40. Clark SK, Phillips RKS. Desmoids in familial adenomatous polyposis. Br J Surg 1996;83:1494-1504. https://doi.org/10.1002/bjs.1800831105
  41. Won YJ, Park KJ, Kwon HJ, Lee JH, Kim JH, Kim YJ, et al. Germline mutations of the APC gene in Korean familial adenomatous polyposis patients. J Hum Genet 1999;44:103-8. https://doi.org/10.1007/s100380050118
  42. Kim DW, Kim IJ, Kang HC, Park HW, Shin Y, Park JH, et al. Mutation spectrum of the APC gene in 83 Korean FAP families. Hum Mutat 2005;26:281.
  43. Choi HS, Park YJ, Park JG, Yoon KA, Ku JL, Kim NK, et al. Clinical characteristics of Peutz-Jeghers syndrome in Korean polyposis patients. Int J Colorectal Dis 2000;15:35-8. https://doi.org/10.1007/s003840050005
  44. Kim IJ, Ku JL, Yoon KA, Heo SC, Jeong SY, Choi HS, et al. Germline mutation of the dpc4 gene in Korean juvenile polyposis patients. Int J Cancer 2000;86: 529-32. https://doi.org/10.1002/(SICI)1097-0215(20000515)86:4<529::AID-IJC14>3.0.CO;2-O
  45. Kim IJ, Park JH, Kang HC, Kim KH, Kim JH, Ku JL, et al. Identification of a novel BMPR1A germline mutation in a Korean juvenile polyposis patient without SMAD4 mutation. Clin Genet 2003;63:126-30. https://doi.org/10.1034/j.1399-0004.2003.00008.x
  46. Al-Tassan, Chmiel NH, Maynard J, Fleming N, Livingston AL, Williams GT, et al. Inherited variants of MYH associated with somatic G:C${\rightarrow}$T:A mutations in colorectal tumors. Nat Genet 2002;30:227-32. https://doi.org/10.1038/ng828
  47. Kim DW, Kim IJ, Kang HC, Jang SG, Kim K, Yoon HJ, et al. Germline mutations of the MYH gene in Korean patients with multiple colorectal adenomas. Int J Colorectal Dis 2007;22:1173-8. https://doi.org/10.1007/s00384-007-0289-8
  48. Jeong SY. Hereditary cancer and genetic counseling. J Genet Med 2007 4:15-21.